Pulmaxan
Stock Recap #PipelineProspector

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

The month of May saw investors grow increasingly cautious. This resulted in a dip in the biotech ind

Pipeline Prospector Feb 2024: Novo’s parent buys Catalent for US$ 16.5 bn, FDA okays Iovance’s cell therapy

February was a good month for the pharma sector, complete with some important deals, successes from